Clinical Trials for Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation

Find clinical trials for used in patients receiving anticoagulant therapy (e.g., rivaroxaban or apixaban, inhibitors of coagulation factor xa) who require reversal of anticoagulation. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Phase I Study of MT1011 Injection in Healthy Subjects

NCT ID: NCT07024160

This clinical trial is testing a new medicine called MT1011, which is designed to help people who are taking blood thinners like rivaroxaban or apixaban and may need their blood thinning effects re...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions